Telaprevir Experience From Turkey


KÖMÜR S. , KURTARAN B. , İNAL A. S. , PULLUKÇU H., ULU A. , Kuscu F. , ...More

HEPATITIS MONTHLY, vol.15, no.2, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.5812/hepatmon.25639
  • Title of Journal : HEPATITIS MONTHLY

Abstract

Background: In patients with chronic hepatitis C, triple drug regimens containing a protease inhibitor, peginterferon and ribavirin were found to significantly increase sustained virologic response rates compared to dual drug regimen containing pegylated interferon and ribavirin, especially in genotype 1.